KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Haleon 111.53 Bn 109.67 Bn - -
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn 33.22%
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn 2.94%
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn 4.50%
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn 26.82%
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn 66.11%
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn - -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn -17.90%
9 HUTCHMED (China) 10.36 Bn 9.02 Bn - -
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn -30.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.22%
Dec 31, 2025 30.43%
Sep 30, 2025 37.91%
Jun 30, 2025 31.16%
Mar 31, 2025 28.32%
Dec 31, 2024 36.80%
Sep 30, 2024 -1.64%
Jun 30, 2024 -11.60%
Mar 31, 2024 31.70%
Dec 31, 2023 -44.65%
Sep 30, 2023 51.18%
Jun 30, 2023 -136.12%
Mar 31, 2023 -154.84%
Dec 31, 2022 -177.40%
Sep 30, 2022 -29.82%
Jun 30, 2022 -15.77%
Mar 31, 2022 -162.03%
Dec 31, 2021 27.57%
Sep 30, 2021 -35.42%
Jun 30, 2021 -47.73%
Mar 31, 2021 -41.72%
Dec 31, 2020 26.26%
Sep 30, 2020 -116.91%
Jun 30, 2020 26.48%
Mar 31, 2020 -50.82%
Dec 31, 2019 28.18%
Sep 30, 2019 -25.99%
Jun 30, 2019 -25.99%
Mar 31, 2019 -29.75%
Dec 31, 2018 -100.51%
Sep 30, 2018 -66.92%
Jun 30, 2018 -34.76%
Mar 31, 2018 33.24%
Dec 31, 2017 -166.30%
Sep 30, 2017 -18.83%
Jun 30, 2017 -112.26%
Mar 31, 2017 -14.38%
Dec 31, 2016 -64.04%
Sep 30, 2016 8,040.91%
Jun 30, 2016 6,900.46%
Mar 31, 2016 -8.29%
Dec 31, 2015 35.49%
Sep 30, 2015 35.38%
Jun 30, 2015 -9.58%
Mar 31, 2015 -14.68%
Dec 31, 2014 22.25%
Sep 30, 2014 4.88%
Jun 30, 2014 14.83%
Mar 31, 2014 8.67%
Dec 31, 2013 -15.98%
Sep 30, 2013 -14.00%
Jun 30, 2013 -39.39%
Mar 31, 2013 2.36%
Dec 31, 2012 -18.10%
Sep 30, 2012 -32.91%
Jun 30, 2012 12.79%
Mar 31, 2012 26.95%